04.09.25 -- Business Of Biotech 2.0 With Ben Comer

In this 4-part series, learn about AI-driven methods that streamline data mapping and highlight critical issues that allow clinical teams to focus on what truly matters.

Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.

East Carolina University and UNC Charlotte have achieved R1 status. Discover how their significant research contributions enhance North Carolina's reputation as a life sciences hub.

This presentation addresses the critical need for high-throughput, reliable analytical development strategies to support expedited Investigational New Drug (IND) applications.

Participant payments in clinical trials have long been fraught with inconsistency, raising questions about the role of IRBs, tax implications, and fair reimbursement structures.